287 related articles for article (PubMed ID: 16029327)
21. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
[TBL] [Abstract][Full Text] [Related]
22. Extracorporeal photopheresis differentially regulates the expression of phosphorylated STAT-1 and STAT-5 in treated monocytes and T cells, respectively.
Bladon J; Taylor P
J Cutan Med Surg; 2004; 8(3):148-56. PubMed ID: 15578129
[TBL] [Abstract][Full Text] [Related]
23. Impact of psoralen/UVA-treatment on survival, activation, and immunostimulatory capacity of monocyte-derived dendritic cells.
Holtick U; Marshall SR; Wang XN; Hilkens CM; Dickinson AM
Transplantation; 2008 Mar; 85(5):757-66. PubMed ID: 18337671
[TBL] [Abstract][Full Text] [Related]
24. Extracorporeal photochemotherapy induces arginase 1 in patients with graft versus host disease.
Merlin E; Goncalves-Mendes N; Hannani D; de la Torre A; Farges MC; Laroye H; Demeocq F; Kanold J; Vasson MP
Transpl Immunol; 2011 Jan; 24(2):100-6. PubMed ID: 21040785
[TBL] [Abstract][Full Text] [Related]
25. Treatment of graft versus host disease (GVHD) by photopheresis?
Schooneman F; Claise C
Transfus Sci; 1996 Dec; 17(4):527-36. PubMed ID: 10168550
[TBL] [Abstract][Full Text] [Related]
26. Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis.
French LE; Alcindor T; Shapiro M; McGinnis KS; Margolis DJ; Porter D; Leonard DG; Rook AH; Foss F
Bone Marrow Transplant; 2002 Oct; 30(8):509-15. PubMed ID: 12379890
[TBL] [Abstract][Full Text] [Related]
27. Extracorporeal photopheresis: what is it and when should it be used?
Scarisbrick J
Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
[TBL] [Abstract][Full Text] [Related]
28. Extracorporeal photopheresis: from solid organs to face transplantation.
Hivelin M; Siemionow M; Grimbert P; Lantieri L
Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
[TBL] [Abstract][Full Text] [Related]
29. [Extracorporeal photopheresis as an alternative therapy for drug-resistant graft versus host disease: three cases].
D'incan M; Kanold J; Halle P; De Lumley L; Souteyrand P; Deméocq F
Ann Dermatol Venereol; 2000 Feb; 127(2):166-70. PubMed ID: 10739974
[TBL] [Abstract][Full Text] [Related]
30. Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination.
Capitini CM; Davis JP; Larabee SM; Herby S; Nasholm NM; Fry TJ
Biol Blood Marrow Transplant; 2011 Jun; 17(6):790-9. PubMed ID: 21216299
[TBL] [Abstract][Full Text] [Related]
31. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
Kanold J; Merlin E; Halle P; Paillard C; Marabelle A; Rapatel C; Evrard B; Berger C; Stephan JL; Galambrun C; Piguet C; D'Incan M; Bordigoni P; Deméocq F
Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
[TBL] [Abstract][Full Text] [Related]
32. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
Bisaccia E; Palangio M; Gonzalez J; Adler KR; Scarborough R; Goldberg SL; Rowley SD
J Clin Apher; 2006 Oct; 21(3):181-7. PubMed ID: 16607632
[TBL] [Abstract][Full Text] [Related]
33. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo.
Bladon J; Taylor P
J Clin Apher; 2002; 17(4):177-82. PubMed ID: 12494410
[TBL] [Abstract][Full Text] [Related]
34. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis.
George JF; Gooden CW; Guo L; Kirklin JK
J Heart Lung Transplant; 2008 Jun; 27(6):616-22. PubMed ID: 18503960
[TBL] [Abstract][Full Text] [Related]
35. Extracorporeal photochemotherapy.
Maeda A
J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
[TBL] [Abstract][Full Text] [Related]
36. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD).
Child FJ; Ratnavel R; Watkins P; Samson D; Apperley J; Ball J; Taylor P; Russell-Jones R
Bone Marrow Transplant; 1999 May; 23(9):881-7. PubMed ID: 10338042
[TBL] [Abstract][Full Text] [Related]
38. Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells.
Gerner M; Hölig K; Wehner R; Zhao S; Schäkel K; Bachmann MP; Rieber EP; Bornhäuser M; Schmitz M
Transplantation; 2009 Apr; 87(8):1134-9. PubMed ID: 19384158
[TBL] [Abstract][Full Text] [Related]
39. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
[TBL] [Abstract][Full Text] [Related]
40. Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease.
Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D
Transplantation; 2008 Jun; 85(12):1826-32. PubMed ID: 18580477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
